{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:42:34Z","timestamp":1789666954454,"version":"4.0.1"},"reference-count":14,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment of refractory Evans syndrome (ES) remains a challenge in hematology practice. Due to rarity of this condition, evidence\u2010based approaches are limited and often treatment choices stem from small case series or anecdotal experiences. There is mounting evidence that some patients have genetic defects that could be targeted with promising preliminary results. Here, we describe three very refractory pediatric ES cases treated on bortezomib without adverse effects. Two of the three patients had dramatic and long\u2010lasting recovery that started following the initial doses of the drug. Clinical trials to assess the role of bortezomib in ES treatment are warranted.<\/jats:p>","DOI":"10.1002\/pbc.28725","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T05:56:03Z","timestamp":1600926963000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bortezomib treatment of steroid\u2010refractory Evans syndrome in children"],"prefix":"10.1002","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1130-0941","authenticated-orcid":false,"given":"Serina B.","family":"Beydoun","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology Children's Hospital of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-9434","authenticated-orcid":false,"given":"Yogindra","family":"Persaud","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Children's Hospital of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lafferty","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Children's Hospital of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8742-0275","authenticated-orcid":false,"given":"Michael U.","family":"Callaghan","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Children's Hospital of Michigan Department of Pediatrics Barbara Ann Karmanos Cancer Center Children's Hospital of Michigan Central Michigan University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-3027","authenticated-orcid":false,"given":"S\u00fcreyya","family":"Sava\u015fan","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Children's Hospital of Michigan Department of Pediatrics Barbara Ann Karmanos Cancer Center Children's Hospital of Michigan Central Michigan University College of Medicine"},{"name":"Division of Hematology\/Oncology Pediatric Bone Marrow Transplant Program Children's Hospital of Michigan Department of Pediatrics Barbara Ann Karmanos Cancer Center Children's Hospital of Michigan Central Michigan University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.77.3.245"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13866"},{"key":"e_1_2_5_4_1","first-page":"352","article-title":"Second\u2010line therapy in paediatric warm autoimmune haemolyticanaemia. Guidelines from the Associazione Italiana Onco\u2010Ematologia Pediatrica (AIEOP)","volume":"16","author":"Ladogana S","year":"2018","journal-title":"Blood Transfus"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fped.2016.00003","article-title":"Editorial: current challenges in immune and other acquired cytopenias of childhood","volume":"4","author":"Ghosh S","year":"2016","journal-title":"Front Pediatr"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0000000000001325","article-title":"Successful treatment of an adolescent male with severe refractory Evans syndrome using bortezomib\u2010based therapy","author":"Knight T","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11540"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-887141"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001412"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000517"},{"issue":"10","key":"e_1_2_5_11_1","first-page":"1752","article-title":"Proteasome inhibition with bortezomib induces apoptosis of long\u2010lived plasma cells in steroid\u2010resistant or relapsed immune thrombocytopaenia","volume":"118","author":"Li G","year":"2018","journal-title":"ThrombHaemost"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.12.009"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.02.018"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.06.011"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.11.022"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.28725","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pbc.28725","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.28725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T22:58:47Z","timestamp":1693868327000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.28725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1002\/pbc.28725"],"URL":"https:\/\/doi.org\/10.1002\/pbc.28725","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"2020-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e28725"}}